APT Pharmaceuticals Inc

Official name: 
APT Pharmaceuticals Incorporated
Registration country: 
United States
ISIC Code: 
2100
Company type: 
A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations.
Overview: 
APT Pharmaceuticals' initial focus is on the pulmonary delivery of treatments to address unmet need for serious lung diseases. The company is focused on the development of cyclosporine inhalation solution (CIS) for the prevention and treatment of chronic rejection in lung transplantation.